Basak Oyan

Acibadem, 34752, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

Journal: Cancers

Published: May 12, 2026

A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.

A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.

Journal: Medicine

Published: May 24, 2024

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.

Journal: Expert opinion on pharmacotherapy

Published: April 03, 2024

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Journal: BMC cancer

Published: January 23, 2024

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Journal: BMC cancer

Published: February 21, 2023

Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group.

Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group.

Journal: Current problems in cancer

Published: December 23, 2022

Validation of bioelectrical impedance analysis in the evaluation of body composition in patients with breast cancer.

Validation of bioelectrical impedance analysis in the evaluation of body composition in patients with breast cancer.

Journal: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition

Published: July 12, 2022

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.

Journal: Journal of cancer research and clinical oncology

Published: November 30, 2021

Coronaphobia: A barrier to ongoing cancer treatment?

Coronaphobia: A barrier to ongoing cancer treatment?

Journal: Psycho-oncology

Published: October 28, 2021

The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study.

The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: July 16, 2021

Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak.

Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak.

Journal: Turkish journal of surgery

Published: April 24, 2020

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.

Journal: Cancer chemotherapy and pharmacology

Published: July 06, 2018

Showing 1-12 of 39

Last Updated: 09/26/2026